2-(Octadecyloxy)-1,3-dioxan-5-amine (OD) with an
acid degradable ortho
ester group was synthesized, and conjugated to
hyaluronic acid (HA) backbone to prepare pH-responsive and
tumor-targeted hyaluronic acid-2-(octadecyloxy)-1,3-dioxan-5-amine (HOD) conjugates. 1H NMR was used to confirm the structures of the OD and HOD. The studies of pH-responsive behavior showed that HOD
micelles were stable under physiological conditions while they were degraded in the
tumor acidic microenvironment.
Doxorubicin (DOX)-loaded HOD
micelles (DOX/HOD) with a narrow size distribution were prepared and characterized. The increased release of DOX from DOX/HOD
micelles was presented at low pH condition. From in vitro cytotoxicity assays against MCF-7 cells, the blank
micelles exhibited low cytotoxicity, but DOX/HOD
micelles had the higher cytotoxicity than pH insensitive control and free DOX. Cellular uptake experiments and confocal images demonstrated that pH-sensitive DOX/HOD
micelles could be internalized efficiently by CD44 receptor mediated endocytosis, and then DOX was rapidly released due to pH-induced degradable of OD to cell nucleus compared to the non-sensitive
micelles. Furthermore, endocytosis inhibition studies presented that DOX/HOD
micelles were internalized into cells mainly via caveolae-mediated routes. In vivo study of
micelles in
tumor-bearing mice indicates that HOD
micelles were more effectively accumulated into the
tumor tissue than
HOA micelles. These results verify that the pH-sensitive HOD micellar system is a promising nanocarrier for enhanced internalization of
antitumor drugs to
cancer cells.